1. CohenML. The epidemiology of diarrheal diseases in the United States. Infect Dis Clin North Am1988;2:557.

2. GuerrantRL, Van GilderT, SteinerTS, et al.Practice guidelines for the management of infectious diarrhea. Clin Infect Dis2001;32:331. CrossRef

3. RussoMW, WeiJT, ThinyMT, et al.Digestive and liver diseases statistics, 2004. Gastroenterology2004;126:1448. CrossRef

4. MeadPS, SlutskerL, DietzV, et al.Food‐related illness and death in the United States. Emerg Infect Dis1999;5:607. CrossRef

5. Casburn‐JonesAC, FarthingMJ. Management of infectious diarrhea. Gut2004;53:296. CrossRef

6. ImhoffB, MorseD, ShiferawB, et al.Burden of self‐reported acute diarrhea illness in FoodNet surveillance areas, 1998–1999. Clin Infect Dis2004;38 (Suppl):S219. CrossRef

7. WheelerJG, SethiD, CowdenJM, et al.Study of infectious disease in England: rates in the community, presenting to general practice, and reported to national surveillance. BMJ1999;318:1046. CrossRef

8. MajowiczSE, DoréK, FlintJA, et al.Magnitude and distribution of acute, self‐reported gastrointestinal illness in a Canadian community. Epidemiol Infect2004;132:607. CrossRef

9. TamCC, O'BrienSJ, TompkinsDS, et al.Changes in causes of acute gastroenteritis in the United Kingdom over 15 years: microbiologic findings from 2 prospective, population‐based studies of infectious intestinal disease. Clin Infect Dis2012;54:1275. CrossRef

10. JonesTF, BulensSN, GettnerS, et al.Use of stool collection kits delivered to patients can improve confirmation of etiology in foodborne disease outbreaks. Clin Infect Dis2004;39:1454. CrossRef

11. TalanD, MoranGJ, NewdowM, et al.Etiology of bloody diarrhea among patients presenting to United States emergency departments: prevalence of Escherichia coli O157:H7 and other enteropathogens. Clin Infect Dis2001;32:573. CrossRef

12. GlassRI, KilgorePE, HolmanRC, et al.The epidemiology of rotavirus diarrhea in the United States: surveillance and estimates of disease burden. J Infect Dis1996;174 (Suppl):S5. CrossRef

13. Centers for Disease Control and Prevention. Outbreak of acute gastroenteritis associated with Norwalk‐like viruses among British military personel, May 2002. MMWR Morb Mortal Wkly Rep2002;51:477.

14. FankhauserRL, MonroeSS. Epidemiologic and molecular trends of ‘Norwalk‐like viruses’ associated with outbreaks of gastroenteritis in the United States. J Infect Dis2002;186:1. CrossRef

15. Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention. Updated norovirus outbreak management and disease prevention guidelines. MMWR Recomm Rep2011;60(RR‐3):1.

16. RodriguezWJ, KimHW, ArrobioJO, et al.Clinical features of acute gastroenteritis associated with human reovirus‐like agent in infants and young children. J Pediatr1977;91:188. CrossRef

17. CorteseMM, ParasharUD; Centers for Disease Control and Prevention. Prevention of rotavirus gastroenteritis among infants and children. MMWR Recomm Rep2009;58(RR‐2):1.

18. ParasharUD, HummelmanEG, BreseeJS, et al.Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis2003;9:565. CrossRef

19. TateJE, MutucJD, PanozzoCA, et al.Sustained decline in rotavirus detections in the United States following the introduction of rotavirus vaccine in 2006. Pediatr Infect Dis J2011;30(1 Suppl):S30. CrossRef

20. Centers for Disease Control and Prevention (CDC). Preliminary FoodNet data on the incidence of foodborne illnesses–selected sites, United States, 2002. MMWR Morb Mortal Wkly Rep2003;52:340.

21. DialS, DelaneyJA, BarkunAN, et al.Use of gastric acid‐suppressive agents and the risk of community‐acquired Clostridium difficile‐associated disease. JAMA2005;294:2989. CrossRef

22. MylonakiM, LangmeadL, PantesA, et al.Enteric infection in relapse of inflammatory bowel disease: importance of microbiological examination of stool. Eur J Gastroenterol Hepatol2004;16:775. CrossRef

23. Van NoodE, VriezeA, NieuwdorpM, et al.Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med2013;368:407. CrossRef

24. KassamZ, LeeCH, YuanY, et al.Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta‐analysis. Am J Gastroenterol2013;108:500. CrossRef

25. ScogingA, BahlM. Diarrhetic shellfish poisoning in the UK. Lancet1998;352:117. CrossRef

26. BeckerK, SouthwickK, ReardonJ, et al.Histamine poisoning associated with eating tuna burgers. JAMA2001;285:1327. CrossRef

27. GrattanLM, OldachDF, PerlTM, et al.Learning and memory difficulties after environmental exposure to waterways containing toxin‐producing Pfiesteria or Pfiesteria‐like dinoflagellates. Lancet1998;352:532. CrossRef

28. AhmedFE. Seafood Safety. Washington, D.C.: National Academy Press; 1991.

29. MorrisJGJr. Natural toxins associated with fish and shellfish. In: BlaserMJ, SmithPD, RavdinJI, et al. (eds). Infections of the Gastrointestinal Tract. New York: Raven Press; 1995: 251.

30. American Medical Association, Centers for Diseases Control and Prevention, Center for Food Safety and Applied Nutrition, Food and Drug Administration, Food Safety and Inspection Service, US Department of Agriculture. Diagnosis and management of foodborne illnesses: a primer for physicians and other health care professionals. MMWR Recomm Rep2004;53(RR‐4):1

31. HillDR, EricssonCD, PearsonRD, et al.; Infectious Diseases Society of America. The practice of travel medicine: guidelines by the Infectious Diseases Society of America. Clin Infect Dis2006;43:1499. CrossRef

32. DuPontHL, CapsutoEG. Persistent diarrhea in travelers. Clin Infect Dis1996;22:124. CrossRef

33. SanchezJL, GelnettJ, PetruccelliBP. Diarrheal diseases incidence and morbidity among United States military personnel during short term missions oversees. Am J Trop Med Hyg1998;58:299.

34. RiddleM, SandersJ. Incidence, etiology, and impact of diarrhea on long‐term‐travelers (US military and similar populations). Am J Trop Med Hyg2006;74:891.

35. GoodwinL, BourkeJ. Irritable bowel syndrome in the UK military after deployment to Iraq: what are the risk factors?Soc Psychiatry Psychiatr Epidemiol2013;48:1755. CrossRef

36. PorterCK, GloorK. Risk of functional gastrointestinal disorders in U.S. military following self‐reported diarrhea and vomiting during deployment. Dig Dis Sci2011;56:3262. CrossRef

37. EkanemEE, DuPontHL, PickeringLK, et al.Transmission dynamics of enteric bacteria in day‐care centers. Am J Epidemiol1983;118:562.

38. PickeringLK, WoodwardWE. Diarrhea in day care centers. Pediatr Infect Dis1982;1:47. CrossRef

39. RevesRR, MorrowAL, BartlettAVIII, et al.Child day care increases the risk of clinic visits for acute diarrhea and diarrhea due to rotavirus. Am J Epidemiol1993;137:97.

40. OttSJ, MusfeldtM, WenderothDF, et al.Reduction in the diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut2004;53:685. CrossRef

41. HarrellL, WangY, AntonopoulosD, et al.Standard colonic lavage alters the natural state of mucosal‐associated microbiota in the human colon. PLoS ONE2012;7:e32545. CrossRef

42. BartlettJG. Clinical practice. Antibiotic‐associated diarrhea. N Engl J Med2002;346:334. CrossRef

43. ThorpeCM, GorbachSL. Update on Clostridium difficile. Curr Treat Options Gastroenterol2006;9:265. CrossRef

44. MylonakisE, RyanET, CalderwoodSB. Clostridium difficile‐associated diarrhea: a review. Arch Intern Med2001;161:525. CrossRef

45. LooVG, PoirierL, MillerMA, et al.A predominantly clonal multi‐institutional outbreak of Clostridium difficile‐associated diarrhea with high morbidity and mortality. N Engl J Med2005;353:2442. CrossRef

46. BartlettJG. Narrative review: the new epidemic of Clostridium difficile‐associated enteric disease. Ann Intern Med2006;145:758. CrossRef

47. SzajewskaH, MrukowiczJ. Meta‐analysis: non‐pathogenic yeast Saccharomyces boulardii in the prevention of antibiotic‐associated diarrhea. Aliment Pharmacol Ther2005;22:365. CrossRef

48. BoleySJ, BrandtLJ, VeithFJ. Ischemic disorders of the intestines. Curr Probl Surg1978;15:1. CrossRef

49. MontejoJC. Enteral nutrition‐related gastrointestinal complications in critically ill patients: a multicenter study. Crit Care Med1999;27:1447. CrossRef

50. GottschlichMM, WardenGD, MichelM, et al.Diarrhea in tube‐fed burn patients: incidence, etiology, nutritional impact, and prevention. JPEN J Parenter Enteral Nutr1988;12:338. CrossRef

51. ThakkarK, KienCL, RosenblattJI, et al.Diarrhea in severely burned children. JPEN J Parenter Enteral Nutr2005;29:8. CrossRef

52. KornblauS, BensonAB, CatalanoR, et al.Management of cancer treatment‐related diarrhea. Issues and therapeutic strategies. J Pain Symptom Manage2000;19:118. CrossRef

53. GremJL, ShoemakerDD, PetrelliNJ, et al.Severe and fatal toxic effects observed in treatment with high‐ and low‐dose leucovorin plus 5‐fluorouracil for colorectal carcinoma. Cancer Treat Rep1987;71:1122.

54. RosenbergSA, LotzeMT, MuleJJ. NIH conference. New approaches to the immunotherapy of cancer using interleukin‐2. Ann Intern Med1988;108:853. CrossRef

55. RiddochC, TrinickT. Gastrointestinal disturbances in marathon runners. Br J Sports Med1988;22:71. CrossRef

56. HeerM, RepondF, HanyA, et al.Acute ischaemic colitis in a female long distance runner. Gut1987;28:896. CrossRef

57. BaskaRS, MosesFM, GraeberG, et al.Gastrointestinal bleeding during an ultramarathon. Dig Dis Sci1990;35:276. CrossRef

58. CroweSE, PerdueMH. Gastrointestinal food hypersensitivity: basic mechanisms of pathophysiology. Gastroenterology1992;103:1075.

59. DuPontHL. Guidelines of acute infectious diarrhea in adults. Am J Gastroenterol1997;92:1962.

60. HuichoL, SanchezD, ContrerasM, et al.Occult blood and fecal leukocytes as screening tests in childhood diarrhea: an old problem revisited. Pediatr Infect Dis J1993;12:474. CrossRef

61. GuerrantRL, ShieldsDS, ThorsonSM, et al.Evaluation and diagnosis of acute infectious diarrhea. Am J Med1985;78:91. CrossRef

62. KaneSV, SandbornWJ, RufoPA, et al.Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation. Am J Gastroenterol2003;98:1309. CrossRef

63. ASGE standards of Practice Committee. The role of endoscopy in patients with diarrhea. Gastrointest Endosc2010;71:887. CrossRef

64. BellemareS, HartlingL, WiebeN, et al.Oral rehydration versus intravenous therapy for treating dehydration due to gastroenteritis in children: a meta‐analysis of randomized controlled trials. BMC Med2004;2:11. CrossRef

65. Aranda‐MichelJ, GiannellaRA. Acute diarrhea: a practical review. Am J Med1999;106:670. CrossRef

66. ScheidlerMD, GiannellaRA. Practical management of acute diarrhea. Hosp Pract (Off Ed)2011;36:49. CrossRef

67. ThielmanNM, GuerrantRL. Clinical practice. Acute infectious diarrhea. N Engl J Med2004;350:38. CrossRef

68. RhoadsM. Management of acute diarrhea in infants. JPEN J Parenter Enteral Nutr1999;23:S18. CrossRef

69. WingateD, PhillipsSF, LewisSJ, et al.Guidelines for adults on self‐medication for the treatment of acute diarrhea. Aliment Pharmacol Ther2001;15:773. CrossRef

70. AllenSJ, MartinezEG, GregorioGV, et al.Probiotics for treating acute infectious diarrhoea. Cochrane Database Syst Rev2010;(11):CD003048.

71. GuerrantRL, Van GilderT, SteinerTS, et al.; Infectious Diseases Society of America. Practice guidelines for the management of infectious diarrhea. Clin Infect Dis2001;32:331. CrossRef

72. YukiN, HartungHP. Guillain‐Barré syndrome. N Engl J Med2012;366:2294. CrossRef

73. ReesJH, SoudainSE, GregsonNA, et al.Campylobacter jejuni infection and Guillain‐Barré syndrome. N Engl J Med1995;333:1374. CrossRef

74. GeorgeJN. Clinical practice. Thrombotic thrombocytopenic purpura. N Engl J Med2006;354:1927. CrossRef

75. KovacsMJ, RoddyJ, GrégoireS, et al.Thrombotic thrombocytopenic purpura following hemorrhagic colitis due to Escherichia coli O157:H7. Am J Med1990;88:177. CrossRef

76. PorterCK, TribbleDR, AliagaPA, et al.Infectious gastroenteritis and risk of developing inflammatory bowel disease. Gastroenterology2008;135:781. CrossRef

77. GradelKO, NielsenHL, SchønheyderHC, et al.Increased short‐ and long‐term risk of inflammatory bowel disease after salmonella or campylobacter gastroenteritis. Gastroenterology2009;137:495. CrossRef

78. García RodríguezLA, RuigómezA, PanésJ. Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease. Gastroenterology2006;130:1588. CrossRef

79. López‐SerranoP, Pérez‐CalleJL, Pérez‐FernándezMT, et al.Environmental risk factors in inflammatory bowel diseases. Investigating the hygiene hypothesis: a Spanish case‐control study. Scand J Gastroenterol2010;45:1464. CrossRef

80. CarterJD, HudsonAP. Reactive arthritis: clinical aspects and medical management. Rheum Dis Clin North Am2009;35:21. CrossRef

81. FineKD, SchillerLR. AGA technical review on the evaluation and management of chronic diarrhea. Gastroenterology1999;116:1464. CrossRef

82. PawlowskiSW, WarrenCA, GuerrantR. Diagnosis and treatment of acute or persistent diarrhea. Gastroenterology2009;136:1874. CrossRef

83. LubeckDP, BennettCL, MazonsonPD, et al.Quality of life and health service use among HIV‐infected patients with chronic diarrhea. J Acquir Immune Defic Syndr Hum Retrovirol1993;6:478.

84. WatsonA, SamoreMH, WankeCA. Diarrhea and quality of life in ambulatory HIV‐infected patients. Dig Dis Sci1996;41:1794. CrossRef

85. PerryA, DellonE, LundJ, et al.Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology2012;143:1179. CrossRef

86. TalleyNJ, O'KeefeEA, ZinsmeisterAR, et al.Prevalence of gastrointestinal symptoms in the elderly: a population‐based study. Gastroenterology1992;102:895.

87. DonBR, KaysenG. Serum albumin: relationship to inflammation and nutrition. Semin Dial2004;17:432. CrossRef

88. ASGE Standards of Practice Committee, ShenB, KhanK, et al.The role of endoscopy in the management of patients with diarrhea. Gastrointest Endosc2010;71:887. CrossRef

89. PetersonJW, WhippSC. Comparison of the mechanisms of action of cholera toxin and the heat‐stable enterotoxins of Escherichia coli. Infect Immun1995;63:1452.

90. JuckettG, TrivediR. Evaluation of chronic diarrhea. Am Fam Physician2011;84:1119.

91. KulkeMH, MayerRJ. Carcinoid tumours. N Engl J Med1999;340:858. CrossRef

92. WuSV, YuanPQ, LaiJ, et al.Activation of Type 1 CRH receptor isoforms induces serotonin release from human carcinoid BON‐1N cells: an enterochromaffin cell model. Endocrinology2011;152:126. CrossRef

93. ZuetenhorstJM, TaalBG. Metastatic carcinoid tumors: a clinical review. Oncologist2005;10:123. CrossRef

94. AggarwalG, ObideenK, WehbiM. Carcinoid tumors: what should increase our suspicion?Cleve Clin J Med2008;75:849. CrossRef

95. SjöblomSM. Clinical presentation and prognosis of gastrointestinal carcinoid tumours. Scand J Gastroenterol1988;23:779. CrossRef

96. van der LelyAJ, de HerderWW. Carcinoid syndrome: diagnosis and medical management. Arq Bras Endocrinol Metabol2005;49:850. CrossRef

97. MatonPN. The carcinoid syndrome. JAMA1988;260:1602. CrossRef

98. GujralDM, BhattacharyyaS. Cardiac manifestations of gastrointestinal carcinoid tumor. Future Cardiol2013;9:479. CrossRef

99. WanP, MoatS, AnsteyA. Pellagra: a review with emphasis on photosensitivity. Br J Dermatol2011;164:1188. CrossRef

100. von der OheM, CamilleriM, KvolsLK, et al.Motor dysfunction of the small bowel and colon in patients with the carcinoid syndrome and diarrhoea. N Engl J Med1993;329:1073. CrossRef

101. FabianE, KumpP, KrejsGJ. Diarrhea caused by circulating agents. Gastroenterol Clin North Am2012;41:603. CrossRef

102. WymengaAN, de VriesEG, LejismaMK, et al.Effects of ondansetron on gastrointestinal symptoms in carcinoid syndrome. Eur J Cancer1998;34:1293. CrossRef

103. DelaunoitT, RubinJ, NeczyporenkoF, et al.Somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine tumors. Mayo Clin Proc2005;80:502. CrossRef

104. Beck‐SickingerAG. Structural characterization and binding sites of G‐protein‐coupled receptors. Drug Discov Today1996;1:502. CrossRef

105. Lévy‐BohbotN, MerleC, GoudetP, et al.Prevalence, characteristics and prognosis of MEN 1‐associated glucagonomas, VIPomas, and somatostatinomas: study from the GTE (Groupe des Tumeurs Endocrines) registry. Gastroenterol Clin Biol2004;28:1075. CrossRef

106. VernerJV, MorrisonAB. Islet cell tumor and a syndrome of refractory watery diarrhea and hypokalemia. Am J Med1958;25:374. CrossRef

107. GardnerJD. Pancreatic cholera. West J Med1975;123:309.

108. NikouGC, ToubanakisC, NikolaouP, et al.VIPomas: an update in diagnosis and management in a series of 11 patients. Hepatogastroenterology2005;52:1259.

109. ChoKJ, VinikAI. Effect of somatostatin analogue (octreotide) on blood flow to endocrine tumors metastatic to the liver: angiographic evaluation. Radiology1990;177:549. CrossRef

110. KraenzlinME, Ch'ngJL, WoodSM, et al.Long‐term treatment of a VIPoma with somatostatin analogue resulting in remission of symptoms and possible shrinkage of metastases. Gastroenterology1985;88:185. CrossRef

111. RoyPK, VenzonDJ, ShojamaneshH, et al.Zollinger‐Ellison syndrome. Clinical presentation in 261 patients. Medicine (Baltimore)2000;79:379. CrossRef

112. BernaMJ, HoffmannKM, SerranoJ, et al.Serum gastrin in Zollinger‐Ellison syndrome: I. Prospective study of fasting serum gastrin in 309 patients from the National Institutes of Health and comparison with 2229 cases from the literature. Medicine (Baltimore)2006;85:295. CrossRef

113. MoshalMG, BroitmanSA, ZamcheckN. Gastrin and absorption. A review. Am J Clin Nutr1970;23:336.

114. MailmanD. Effects of pentagastrin on intestinal absorption and blood flow in the anesthetized dog. J Physiol1980;307:429. CrossRef

115. FieldM. Intestinal ion transport and the pathophysiology of diarrhea. J Clin Invest2003;111:931. CrossRef

116. OzcelebiF, HoltmannMH, RentschRU, et al.Agonist‐stimulated phosphorylation of the carboxyl‐terminal tail of the secretin receptor. Mol Pharmacol1995;48:818.

117. YouCH, CheyWY. Secretin is an enterogastrone in humans. Dig Dis Sci1987;32:466. CrossRef

118. HundahlSA, FlemingID, FremgenAM, et al.A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985–1995. Cancer1998;83:2638. CrossRef

119. KebebewE, ItuartePH, SipersteinAE, et al.Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems. Cancer2000;88:1139. CrossRef

120. OrlandiF, CaraciP, MussaA, et al.Treatment of medullary thyroid carcinoma: an update. Endocr Relat Cancer2001;8:135. CrossRef

121. HazardJB. The C cells (parafollicular cells) of the thyroid gland and medullary thyroid carcinoma. A review. Am J Pathol1977;88:213.

122. MasiL, BrandiML. Calcitonin and calcitonin receptors. Clin Cases Miner Bone Metab2007;4:117.

123. LiuH, SinglaA, AoM, et al.Calcitonin receptor‐mediated CFTR activation in human intestinal epithelial cells. J Cell Mol Med2011;15:2697. CrossRef

124. SteinfeldCM, MoertelCG, WoolnerLB. Diarrhea and medullary carcinoma of the thyroid. Cancer1973;31:1237. CrossRef

125. WalterJRF, PattniSS. Managing bile acid diarrhea. Therap Adv Gastroenterol2010;3:349. CrossRef

126. MekhjianHS, PhillipsSF, HofmannAF. Colonic secretion of water and electrolytes induced by bile acids: perfusion studies in man. J Clin Invest1971;50:1569. CrossRef

127. FrommH, MalavoltiM. Bile acid‐induced diarrhoea. Clin Gastroenterol1986;15:567.

128. HofmannAF, PoleyJR. Role of bile acid malabsorption in pathogenesis of diarrhea and steatorrhea in patients with ileal resection. I. Response to cholestyramine or replacement of dietary long chain triglyceride by medium chain triglyceride. Gastroenterology1972;62:918.

129. WilliamsAJK, MerrickMV, EastwoodMA. Idiopathic bile acid malabsorption a review of clinical presentation, diagnosis, and response to treatment. Gut1991;32:1004. CrossRef

130. FisherM, SpillasDC, TongLK. Diarrhoea after laparoscopic cholecystectomy: incidence and main determinants. ANZ J Surg2008;78:482. CrossRef

131. BarkunAN, LoveJ, GouldM, et al.Bile acid malabsorption in chronic diarrhea: pathophysiology and treatment. Can J Gastroenterol2013;27:653.

132. CananiRB, TerrinG, CirilloP, et al.Butyrate as an effective treatment of congenital chloride diarrhea. Gastroenterology2004;127:630. CrossRef

133. GambleJL, FaheyKR, AppletonJ, et al.Congenital alkalosis with diarrhoea. J Pediatr1945;26:509. CrossRef

134. DarrowDC. Congenital alkalosis with diarrhea. J Pediatr1945;26:519. CrossRef

135. RoseNC, KaplanP, ScottS, et al.Prenatal presentation of congenital chloride diarrhea: clinical report and review of the literature. Am J Perinatol1992;9:398. CrossRef

136. MartinMG, WrightEM. Congenital intestinal transport defects. In: WalkerWA(ed). Pediatric Gastrointestinal Disease, 4th ed. Hamilton, Ontario: BC Decker Inc; 2004: 911.

137. WedenojaS, HöglundP, HolmbergC. Review article: the clinical management of congenital chloride diarrhoea. Aliment Pharmacol Ther2010;31:477. CrossRef

138. AichbichlerBW, ZerrCH, Santa AnaCA, et al.Proton‐pump inhibition of gastric chloride secretion in congenital chloridorrhea. N Engl J Med1997;336:106. CrossRef

139. AmersiF, AgustinM, KoCY. Colorectal cancer: epidemiology, risk factors, and health services. Clin Colon Rectal Surg2005;18:133. CrossRef

140. OlderJ, OlderP, ColkerJ, et al.Secretory villous adenomas that cause depletion syndrome. Arch Intern Med1999;159:879. CrossRef

141. MilesLF, WakemanCJ, FarmerKC. Giant villous adenoma presenting as McKittrick‐Wheelock syndrome and pseudo‐obstruction. Med J Aust2010;192:225.

142. StevenK, LangeP, BukaveK, et al.Prostaglandin E2‐mediated secretory diarrhoea in villous adenoma of rectum: effect of treatment with indomethacin. Gastroenterology1981;80:1562.

143. JacobH, SchlondorffD, St OngeG, et al.Villous adenoma depletion syndrome. Evidence for a cyclic nucleotide‐mediated diarrhea. Dig Dis Sci1985;30:637. CrossRef

144. PopescuA, Orban‐SchiopuAM, BecheanuG, et al.McKittrick‐Wheelock syndrome – a rare cause of acute renal failure. Rom J Gastroenterol2005;14:63.

145. BarendseRM, van den BrandtS, DekkerE, et al.[McKittrick‐Wheelock syndrome]. Ned Tijdschr Geneeskd2013;157:A5567.

146. SmeltAH, MeindersAE, HoekmanK, et al.Secretory diarrhea in villous adenoma of rectum: effect of treatment with somatostatin and indomethacin. Prostaglandins1992;43:567. CrossRef

147. DindaPK, LeddinDJ, BeckIT. Histamine is involved in ethanol‐induced jejunal microvascular injury in rabbits. Gastroenterology1988;95:1227.

148. KvietysPR, PattersonWG, RussellJM, et al.Role of the microcirculation in ethanol‐induced mucosal injury in the dog. Gastroenterology1984;87:562.

149. ChibaT, PhillipsSF. Alcohol‐related diarrhea. Addict Biol2000;5:117. CrossRef

150. BodeJC, BodeC, HeidelbachR, et al.Jejunal microflora in patients with chronic alcohol abuse. Hepatogastroenterology1984;31:30.

151. PerlowW, BaraonaE, LieberCS. Symptomatic intestinal disaccharidase deficiency in alcoholics. Gastroenterology1977;72:680.

152. WegenerM, SchaffsteinJ, DilgerU, et al.Gastrointestinal transit of solid‐liquid meal in chronic alcoholics. Dig Dis Sci1991;36:917. CrossRef

153. SandleGI. Salt and water absorption in the human colon: a modern appraisal. Gut1998;43:294. CrossRef

154. ScrimshawNS, MurrayEB. The acceptability of milk and milk products in populations with a high prevalence of lactose intolerance. Am J Clin Nutr1988;48:1079.

155. BornP. Carbohydrate malabsorption in patients with non‐specific abdominal complaints. World J Gastroenterol2007;13:5687. CrossRef

156. KaraböcüogluM, SökücüS, GökçayG, et al.Carbohydrate malabsorption in acute diarrhea. Indian Pediatr1994;31:1071.

157. SimrenM, StotzerPO. Use and abuse of hydrogen breath tests. Gut2006;55:297. CrossRef

158. RosadoJL, SolomonsNW. Sensitivity and specificity of the hydrogen breath‐analysis test for detecting malabsorption of physiological doses of lactose. Clin Chem1983;29:545.

159. KhouriMR, HuangG, ShiauYF. Sudan stain of fecal fat: new insight into an old test. Gastroenterology1989;96:421.

160. DrummeyGD, BensonJAJr, JonesCM. Microscopical examination of the stool for steatorrhea. N Engl J Med1961;264:85. CrossRef

161. LeedsJS, HopperAD, SidhuR, et al.Some patients with irritable bowel syndrome may have exocrine pancreatic insufficiency. Clin Gastroenterol Hepatol2010;8:433. CrossRef

162. Nousia‐ArvanitakisS. Cystic fibrosis and the pancreas: recent scientific advances. J Clin Gastroenterol1999;29:138. CrossRef

163. DiMagnoEP, GoVL, SummerskillWH. Relations between pancreatic enzyme outputs and malabsorption in severe pancreatic insufficiency. N Engl J Med1973;288:813. CrossRef

164. FiekerA, PhilpottJ, ArmandM. Enzyme replacement therapy for pancreatic insufficiency: present and future. Clin Exp Gastroenterol2011;4:55.

165. PongprasobchaiS. Maldigestion from pancreatic exocrine insufficiency. J Gastroenterol Hepatol2013;28(Suppl 4):99. CrossRef

166. WallaceMB, HawesRH, DurkalskiV, et al.The reliability of EUS for the diagnosis of chronic pancreatitis: interobserver agreement among experienced endosonographers. Gastrointest Endosc2001;53:294. CrossRef

167. TaylorJR, GardnerTB, WaljeeAK, et al.Systematic review: efficacy and safety of pancreatic enzyme supplements for exocrine pancreatic insufficiency. Aliment Pharmacol Ther2010;31:57. CrossRef

168. QuigleyEM, QueraR. Small intestinal bacterial overgrowth: roles of antibiotics, prebiotics, and probiotics. Gastroenterology2006;130(2 Suppl 1):S78. CrossRef

169. GermaineGR, TellefsonLM. Potential role of lysozyme in bactericidal activity of in vitro‐acquired salivary pellicle against Streptococcus faecium 9790. Infect Immun1986;54:846.

170. GiannellaRA, BroitmanSA, ZamcheckN. Gastric acid barrier to ingested microorganisms in man: studies in vivo and in vitro. Gut1972;13:251. CrossRef

171. KimSK. Small intestine transit time in the normal small bowel study. Am J Roentgenol Radium Ther Nucl Med1968;104:522. CrossRef

172. FlochMH, GershengoranW, ElliottS, et al.Bile acid inhibition of the intestinal microflora—a function for simple bile acids. Gastroenterology1971;61:228.

173. DukowiczAC, LacyBE, DevineGM. Small intestinal bacterial overgrowth: a comprehensive review. Gastroenterol Hepatol (N Y)2007;3:112.

174. SuterPM, GolnerBB, GoldinBR, et al.Reversal of protein‐bound vitamin B12 malabsorption with antibiotics in atrophic gastritis. Gastroenterology1991;101:1039.

175. RussellRM, KrasinskiSD, SamloffIM, et al.Folic acid malabsorption in atrophic gastritis: possible compensation by bacterial folate synthesis. Gastroenterology1986;91:1476.

176. KhoshiniR, DaiSC, LezcanoS, et al.A systematic review of diagnostic tests for small intestinal bacterial overgrowth. Dig Dis Sci2008;53:1443. CrossRef

177. SinghVV, ToskesPP. Small bowel bacterial overgrowth: presentation, diagnosis, and treatment. Curr Treat Options Gastroenterol2004;7:19. CrossRef

178. Di StefanoM, MalservisiS, VenetoG, et al.Rifaximin versus chlortetracycline in the short‐term treatment of small intestinal bacterial overgrowth. Aliment Pharmacol Ther2000;14:551. CrossRef

179. LauritanoEC, GabrielliM, ScarpelliniE, et al.Antibiotic therapy in small intestinal bacterial overgrowth: rifaximin versus metronidazole. Eur Rev Med Pharmacol Sci2009;13:111.

180. ShenB, KhanK, IkenberrySO, et al.The role of endoscopy in the management of patients with diarrhea. Gastrointest Endosc2010;71:887. CrossRef

181. AbrahamC, ChoJH. Mechanisms of disease: inflammatory bowel disease. N Engl J Med2009;361:2066. CrossRef

182. BarkasF, LiberopoulosE, KeiA, et al.Electrolyte and acid‐base disorders in inflammatory bowel disease. Ann Gastroenterol2013;26:23.

183. CunninghamKE, TurnerJR. Myosin light chain kinase: pulling the strings of epithelial tight junction function. Ann N Y Acad Sci2012;1258:34. CrossRef

184. LoganJS. Vincent Ketelaer did not describe tropical or non‐tropical sprue or celiac disease in his book De Aphthis Nostratibus seu Belgarum sprouw. Ulster Med J1990;59:204.

185. LosowskyMS. A history of coeliac disease. Dig Dis2008;26:112. CrossRef

186. GreenPH, CellierC. Celiac disease. N Engl J Med2007;357:1731. CrossRef

187. BrocchiE, TomassettiP, MisitanoB, et al.Endoscopic markers in adult coeliac disease. Dig Liver Dis2002;34:177. CrossRef

188. DicksonBC, StreutkerCJ, ShettyR. Coeliac disease: an update for pathologists. J Clin Pathol2006;59:1008. CrossRef

189. HernandezL, GreenPH. Extraintestinal manifestations of celiac disease. Curr Gastroenterol Rep2006;8:383. CrossRef

190. LoginovAS, EkiseninaSI, KrumsLM. Pathogenesis of steatorrhea in chronic diseases of the small intestine. Ter Arkh1984;56:55.

191. VuoristoM, MiettinenTA. The role of fat and bile acid malabsorption in diarrhoea of coeliac disease. Scand J Gastroenterol1987;22:289. CrossRef

192. OjettiV, NuceraG, MignecoA, et al.High prevalence of celiac disease in patients with lactose intolerance. Digestion2005;71:106. CrossRef

193. CataldoF, MarinoV, VenturaA, et al.Prevalence and clinical features of selective immunoglobulin A deficiency in coeliac disease: an Italian multicentre study. Gut1998;42:362. CrossRef

194. NIH Consensus Development Conference on Celiac Disease. NIH Consens State Sci Statements2004;21:1.

195. PaisWP, DuerksenDR, PettigrewNM, et al.How many duodenal biopsy specimens are required to make a diagnosis of celiac disease?Gastrointest Endosc2008;67:1082. CrossRef

196. ReadNW, KrejsGJ, ReadMG, et al.Chronic diarrhea of unknown origin. Gastroenterology1980;76:264.

197. OlesenM, ErikssonS, BohrJ, et al.Microscopic colitis: a common diarrhoeal disease. An epidemiological study in Örebro, Sweden, 1993–1998. Gut2004;53:346. CrossRef

198. GentileNM, KhannaS, LoftusEVJr, et al.The epidemiology of microscopic colitis in Olmsted County from 2002 to 2010: a population‐based study. Clin Gastroenterol Hepatol2014;12:838. CrossRef

199. OtegbayoJ, OtegbeyeF, RotimuO. Microscopic colitis syndrome‐ a review article. J Natl Med Assoc2005;97:678.

200. PardiD, KellyC. Microscopic colitis. Gastroenterology2011;140:1155. CrossRef

201. BurgelN, BojarskiC, MankertzJ, et al.Mechanisms of diarrhea in collagenous colitis. Gastroenterology2002;123:433. CrossRef

202. PardiDS. Microscopic colitis: an update. Inflamm Bowel Dis2004;10:860. CrossRef

203. StroehleinJR. Microscopic colitis. Curr Opin Gastroenterol2004;20:27. CrossRef

204. FreemanHJ. Collagenous mucosal inflammatory diseases of the gastrointestinal tract. Gastroenterology2005;129:338. CrossRef

205. NyhlinN, BohrJ, ErikssonS, et al.Systematic review: microscopic colitis. Aliment Pharmacol Ther2006;23:1525. CrossRef

206. MatteoniCA, GoldblumJR, WangN, et al.Celiac disease is highly prevalent in lymphocytic colitis. J Clin Gastroenterol2001;32:225. CrossRef

207. MiehlkeS, HeymerP, BethkeB, et al.Budesonide treatment for collagenous colitis: a randomized, double‐blind, placebo‐controlled, multicenter trial. Gastroenterology2002;123:978. CrossRef

208. TalleyNJ, ShorterRG, PhillipsSF, et al.Eosinophilic gastroenteritis: a clinicopathological study of patients with disease of the mucosa, muscle layer, and subserosal tissues. Gut1990;31:54. CrossRef

209. CaldwellJH, TennenbaumJI, BronsteinHA. Serum IgE in eosinophilic gastroenteritis. Response to intestinal challenge in two cases. N Engl J Med1975;292:1388. CrossRef

210. GonsalvesN, DoerflerB, YangG, et al.A prospective clinical trial of six food elimination diet or elemental diet in the treatment of adults with eosinophilic gastroenteritis. Gastroenterology2009;136:S1861.

211. MoriA, EnweluzoC, GrierD, et al.Eosinophilic gastroenteritis: review of a rare and treatable disease of the gastrointestinal tract. Case Rep Gastroenterol2013;7:293. CrossRef

212. Pérez‐MillánA, Martín‐LorenteJL, López‐MoranteA, et al.Subserosal eosinophilic gastroenteritis treated efficaciously with sodium cromoglycate. Dig Dis Sci1997;42:342. CrossRef

213. SchwartzDA, PardiDS, MurrayJA. Use of montelukast as steroid‐sparing agent for recurrent eosinophilic gastroenteritis. Dig Dis Sci2001;46:1787. CrossRef

214. KimYJ, PrussinC, MartinB, et al.Rebound eosinophilia after treatment of hypereosinophilic syndrome and eosinophilic gastroenteritis with monoclonal anti‐IL‐5 antibody SCH55700. J Allergy Clin Immunol2004;114:1449. CrossRef

215. KweonMN, YamamotoM, KajikiM, et al.Systemically derived large intestinal CD4(+) Th2 cells play a central role in STAT6‐mediated allergic diarrhea. J Clin Invest2000;106:199. CrossRef

216. AlfaddaAA, StorrMA, ShafferEA. Eosinophilic colitis: an update on pathophysiology and treatment. Br Med Bull2011;100:59. CrossRef

217. ChenMJ, ChuCH, LinSC, et al.Eosinophilic gastroenteritis: clinical experience with 15 patients. World J Gastroenterol2003;9:2813. CrossRef

218. TanAC, KruimelJW, NaberTH. Eosinophilic gastroenteritis treated with non‐enteric‐coated budesonide tablets. Eur J Gastroenterol Hepatol2001;13:425. CrossRef

219. LeeJK, WhittakerSJ, EnnsRA, et al.Gastrointestinal manifestations of systemic mastocytosis. World J Gastroenterol2008;14:7005. CrossRef

220. JensenRT. Gastrointestinal abnormalities and involvement in systemic mastocytosis. Hematol Oncol Clin North Am2000;14:579. CrossRef

221. WoodwardT. Systemic mastocytosis. Curr Treat Options Gastroenterol2003;6:35. CrossRef

222. ArguedasMR, FerranteD. Systemic mastocytosis and giant gastroduodenal ulcer. Gastrointest Endosc2001;54:530. CrossRef

223. WorobecAS. Treatment of systemic mast cell disorders. Hematol Oncol Clin North Am2000;14:659. CrossRef

224. SokolH, Georgin‐LavialleS, Grandpeix‐GuyodoC, et al.Gastrointestinal involvement and manifestations in systemic mastocytosis. Inflamm Bowel Dis2010;16:1247. CrossRef

225. WhippleGH. A hitherto undescribed disease characterized anatomically by deposits of fat and fatty acids in the intestinal and mesenteric lymphatic tissues. Bull Johns Hopkins Hosp1907;18:382.

226. SchoedonG, GoldenbergerD, ForrerR, et al.Deactivation of macrophages with interleukin‐4 is the key to the isolation of Tropheryma whippelii. J Infect Dis1997;176:672. CrossRef

227. PatilS, FantryGT. Connecting the dots: the many systemic manifestations of whipple disease. Gastroenterol Hepatol (N Y)2012;8:63.

228. DobbinsWOIII. The diagnosis of Whipple's disease. N Engl J Med1995;332:390. CrossRef

229. RamaiahC, BoyntonRF. Whipple's disease. Gastroenterol Clin North Am1998;27:683. CrossRef

230. AndersonM. Neurology of Whipple's disease. J Neurol Neurosurg Psychiatry2000;68:2. CrossRef

231. FenollarF, LepidiH, RaoultD. Whipple's endocarditis: review of the literature and comparisons with Q fever, Bartonella infection, and blood culture‐positive endocarditis. Clin Infect Dis2001;33:1309. CrossRef

232. FlemingJL, WiesnerRH, ShorterRG. Whipples disease: clinical biochemical and histopathologic features and assessment of treatment in 29 patients. Mayo Clin Proc1998;63:539. CrossRef

233. von HerbayA. Whipple's disease. Histologic diagnosis after the discovery of Tropheryma whippelii. Pathologe2001;22:82. CrossRef

234. EdouardS, FenollarF, RaoultD. The rise of Tropheryma whipplei: a 12‐year retrospective study of PCR diagnoses in our reference center. J Clin Microbiol2012;50:3917. CrossRef

235. MisbahSA, MapstoneNP. Whipple's disease revisited. J Clin Pathol2000;53:750. CrossRef

236. SwartzMN. Whipple's disease–past, present, and future. N Engl J Med2000;342:648. CrossRef

237. DesnuesB, Al MoussawiK, FenollarF. New insights into Whipple's disease and Tropheryma whipplei infections. Microbes Infect2010;12:1102. CrossRef

238. FenollarF, PuéchalX, RaoultD. Whipple's disease. N Engl J Med2007;356:55. CrossRef

239. O'BrienW. Tropical sprue: a review. J R Soc Med1979;72:916.

240. BrownIS, BettingtonA, BettingtonM, et al.Tropical sprue: revisiting an underrecognized disease. Am J Surg Pathol2014;38:666. CrossRef

241. WestergaardH. Tropical sprue. Curr Treat Options Gastroenterol2004;7:7. CrossRef

242. MurrayJA, Rubio‐TapiaA. Diarrhoea due to small bowel diseases. Best Pract Res Clin Gastroenterol2012;26:581. CrossRef

243. KaukinenK, PartanenJ, MäkiM, et al.HLA‐DQ typing in the diagnosis of celiac disease. Am J Gastroenterol2002;97:695. CrossRef

244. ChassanyO, MichauxA, BergmannJF. Drug‐induced diarrhoea. Drug Saf2000;22:53. CrossRef

245. PilottoA, FranceschiM, VitaleD, et al.; FIRI (Fondazione Italiana Ricerca sull'Invecchiamento) and SOFIA Project Investigators. The prevalence of diarrhea and its association with drug use in elderly outpatients: a multicenter study. Am J Gastroenterol2008;103:2816. CrossRef

246. KwokCS, ArthurAK, AnibuezeCI, et al.Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta‐analysis. Am J Gastroenterol2012;107:1011. CrossRef

247. DegaetaniM, TennysonCA, LebwohlB, et al.Villous atrophy and negative celiac serology: a diagnostic and therapeutic dilemma. Am J Gastroenterol2013;108:647. CrossRef

248. UklejaA. Dumping syndrome: pathophysiology and treatment. Nutr Clin Pract2000;20:517. CrossRef

249. ScarpignatoC. The place of octreotide in the medical management of the dumping syndrome. Digestion1996;57(Suppl 1):114. CrossRef

250. CheadleWG, BakerPR, CuschieriA. Pyloric reconstruction for severe vasomotor dumping after vagotomy and pyloroplasty. Ann Surg1985;202:568. CrossRef

251. BuchmanAL. Etiology and initial management of short bowel syndrome. Gastroenterology2006;130(2 Suppl 1):S5. CrossRef

252. KumpfVJ. Pharmacologic management of diarrhea in patients with short bowel syndrome. JPEN J Parenter Enteral Nutr2014;38(1 Suppl):38S. CrossRef

253. ParekhN, SeidnerD, SteigerE. Managing short bowel syndrome: making the most of what the patient still has. Cleve Clin J Med2005;72:833. CrossRef

254. CarbonnelF, CosnesJ, ChevretS, et al.The role of anatomic factors in nutritional autonomy after extensive small bowel resection. JPEN J Parenter Enteral Nutr1996;20:275. CrossRef

255. FishbeinTM. Intestinal transplantation. N Engl J Med2009;361:998. CrossRef

256. VipperlaK, O'KeefeSJ. Study of teduglutide effectiveness in parenteral nutrition‐dependent short‐bowel syndrome subjects. Expert Rev Gastroenterol Hepatol2013;7:683. CrossRef

257. ScarlettY. Medical management of fecal incontinence. Gastroenterology2004;126(1 Suppl 1):S55. CrossRef

258. WingeK, RasmussenD, WerdelinLM. Constipation in neurological diseases. J Neurol Neurosurg Psychiatry2003;74:13. CrossRef

259. CappellMS. Pathophysiology, clinical presentation, and management of colon cancer. Gastroenterol Clin North Am2008;37:1. CrossRef

260. DuchenLW, AnjorinA, WatkinsPJ, et al.Pathology of autonomic neuropathy in diabetes mellitus. Ann Intern Med1980;92:301. CrossRef

261. LysyJ, IsraeliE, GoldinE. The prevalence of chronic diarrhea among diabetic patients. Am J Gastroenterol1999;94:2165. CrossRef

262. SchillerLR, Santa AnaCA, SchmulenAC, et al.Pathogenesis of fecal incontinence in diabetes mellitus: evidence for internal‐anal‐sphincter dysfunction. N Engl J Med1982;307:1666. CrossRef

263. American Diabetes Association. Standards of medical care in diabetes–2011. Diabetes Care2011;34(Suppl 1):S11. CrossRef

264. FedorakRN, FieldM, ChangEB. Treatment of diabetic diarrhea with clonidine. Ann Intern Med1985;102:197. CrossRef

265. BaileyCJ, TurnerRC. Metformin. N Engl J Med1996;334:574. CrossRef

266. KennedyGD, HeiseCP. Radiation colitis and proctitis. Clin Colon Rectal Surg2007;20:64. CrossRef

267. NguyenNP, AntoineJE, DuttaS, et al.Current concepts in radiation enteritis and implications for future clinical trials. Cancer2002;95:1151. CrossRef

268. Hauer‐JensenM. Late radiation injury of the small intestine. Clinical, pathophysiologic and radiobiologic aspects. A review. Acta Oncol1990;29:401. CrossRef

269. HensonC. Chronic radiation proctitis: issues surrounding delayed bowel dysfunction post‐pelvic radiotherapy and an update on medical treatment. Therap Adv Gastroenterol2010;3:359. CrossRef

270. HarbAH, AbouFC, ShararaAI. Radiation enteritis. Curr Gastroenterol Rep2014;16:383. CrossRef

271. EddiR, DepasqualeJR. Radiofrequency ablation for the treatment of radiation proctitis: a case report and review of literature. Therap Adv Gastroenterol2013;6:69. CrossRef

272. AndreyevJ. Gastrointestinal complications of pelvic radiotherapy: are they of any importance?Gut2005;54:1051. CrossRef

273. ManichanhC, VarelaE, MartinezC, et al.The gut microbiota predispose to the pathophysiology of acute postradiotherapy diarrhea. Am J Gastroenterol2008;103:1754. CrossRef

274. SekhonS. Chronic radiation enteritis: women's food tolerances after radiation treatment for gynecologic cancer. J Am Diet Assoc2000;100:941. CrossRef

275. SandlerRS, EverhartJE, DonowitzM, et al.The burden of selected digestive diseases in the United States. Gastroenterology2002;122:1500. CrossRef

276. HunginAP, WhorwellPJ, TackJ, et al.The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects. Aliment Pharmacol Ther2003;17:643. CrossRef

277. MearinF, BalboaA, BadiaX, et al.Irritable bowel syndrome subtypes according to bowel habit: revisiting the alternating subtype. Eur J Gastroenterol Hepatol2003;15:165. CrossRef

278. SchmidtT, HackelsbergerN, WidmerR, et al.Ambulatory 24‐hour jejunal motility in diarrhea‐predominant irritable bowel syndrome. Scand J Gastroenterol1996;31:581. CrossRef

279. BouinM, PlourdeV, BoivinM, et al.Rectal distention testing in patients with irritable bowel syndrome: sensitivity, specificity, and predictive values of pain sensory thresholds. Gastroenterology2002;122:1771. CrossRef

280. LiebregtsT, AdamB, BredackC, et al.Immune activation in patients with irritable bowel syndrome. Gastroenterology2007;132:913. CrossRef

281. TörnblomH, LindbergG, NybergB, et al.Full‐thickness biopsy of the jejunum reveals inflammation and enteric neuropathy in irritable bowel syndrome. Gastroenterology2002;123:1972. CrossRef

282. MönnikesH. Quality of life in patients with irritable bowel syndrome. J Clin Gastroenterol2011;45(Suppl):S98. CrossRef

283. DelvauxM, LouvelD, MametJP, et al.Effect of alosetron on responses to colonic distension in patients with irritable bowel syndrome. Aliment Pharmacol Ther1998;12:849. CrossRef

284. SimrénM, MånssonA, LangkildeAM, et al.Food‐related gastrointestinal symptoms in the irritable bowel syndrome. Digestion2001;63:108.

285. VerniaP, Di CamilloM, MarinaroV. Lactose malabsorption, irritable bowel syndrome and self‐reported milk intolerance. Dig Liver Dis2001;33:234. CrossRef

286. HalmosEP, PowerVA, ShepherdSJ, et al.A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology2014;146:67. CrossRef

287. MoayyediP, FordAC, TalleyNJ, et al.The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut2010;59:325. CrossRef

288. MarshallJK, ThabaneM, BorgaonkarMR, et al.Postinfectious irritable bowel syndrome after a food‐borne outbreak of acute gastroenteritis attributed to a viral pathogen. Clin Gastroenterol Hepatol2007;5:457. CrossRef

289. MarshallJK, ThabaneM, GargAX, et al.Incidence and epidemiology of irritable bowel syndrome after a large waterborne outbreak of bacterial dysentery. Gastroenterology2006;131:445. CrossRef

290. WangLH, FangXC, PanGZ. Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis. Gut2004;53:1096. CrossRef

291. CremonC, StanghelliniV, PallottiF, et al.Salmonellosis gastroenteritis during childhood is a risk factor for irritable bowel syndrome in adulthood. Gastroenterology2014;147:69. CrossRef

292. DizdarV, GiljaOH, HauskenT. Increased visceral sensitivity in Giardia‐induced postinfectious irritable bowel syndrome and functional dyspepsia. Effect of the 5HT3‐antagonist ondansetron. Neurogastroenterol Motil2007;19:977.

293. RuigómezA, García RodríguezLA, PanésJ. Risk of irritable bowel syndrome after an episode of bacterial gastroenteritis in general practice: influence of comorbidities. Clin Gastroenterol Hepatol2007;5:465. CrossRef

294. PicheT, BarbaraG, AubertP, et al.Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators. Gut2009;58:196. CrossRef

295. KassinenA, Krogius‐KurikkaL, MäkivuokkoH, et al.The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology2007;133:24. CrossRef

296. MalinenE, RinttiläT, KajanderK, et al.Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real‐time PCR. Am J Gastroenterol2005;100:373. CrossRef

297. WangH, GongJ, WangW, et al.Are there any different effects of Bifidobacterium, Lactobacillus and Streptococcus on intestinal sensation, barrier function and intestinal immunity in PI‐IBS mouse model?PLoS ONE2014;9:e90153. CrossRef

298. JungIS, KimHS, ParkH, et al.The clinical course of postinfectious irritable bowel syndrome: a five‐year follow‐up study. J Clin Gastroenterol2009;43:534. CrossRef

299. NealKR, BarkerL, SpillerRC. Prognosis in post‐ infective irritable bowel syndrome: a six year follow up study. Gut2002;51:410. CrossRef

300. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM‐5). Arlington, VA: American Psychiatric Association; 2013.

301. BytzerP, StokholmM, AndersenI, et al.Prevalence of surreptitious laxative abuse in patients with diarrhoea of uncertain origin: a cost benefit analysis of a screening procedure. Gut1989;30:1379. CrossRef

302. PhillipsSF. Surreptitious laxative abuse: keep it in mind. Semin Gastrointest Dis1999;10:132.

303. TopazianM, BinderHJ. Brief report: factitious diarrhea detected by measurement of stool osmolality. N Engl J Med1994;330:1418. CrossRef

304. SheltonJH, Santa AnaCA, ThompsonDR, et al.Factitious diarrhea induced by stimulant laxatives: accuracy of diagnosis by a clinical reference laboratory using thin layer chromatography. Clin Chem2007;53:85. CrossRef

305. DuncanA. Screening for surreptitious laxative abuse. Ann Clin Biochem2000;37:1. CrossRef

306. BarnesPR, Lennard‐JonesJE, HawleyPR, et al.Hirschsprung's disease and idiopathic megacolon in adults and adolescents. Gut1986;27:534. CrossRef

307. CutzE, RhoadsJM, DrummB, et al.Microvillus inclusion disease: an inherited defect of brush‐border assembly and differentiation. N Engl J Med1989;320:646. CrossRef

308. SawczenkoA, SandhuBK. Newer diarrheal syndromes. Indian J Pediatr1999;66:S46.

309. WangJ, CortinaG, WuSV. Mutant neurogenin‐3 in congenital malabsorptive diarrhea. N Engl J Med2006;355:270. CrossRef

310. Pode‐ShakkedB, ReishO, Aktuglu‐ZeybekC, et al.Bitterness of glucose/galactose: novel mutations in the SLC5A1 gene. J Pediatr Gastroenterol Nutr2014;58:57. CrossRef

311. SanderP, AlfalahM, KeiserM, et al.Novel mutations in the human sucrase‐isomaltase gene (SI) that cause congenital carbohydrate malabsorption. Hum Mutat2006;27:119. CrossRef

312. SackDA, SackRB, ChaignatCL. Getting serious about cholera. N Engl J Med2006;355:649. CrossRef

313. MahlerH, PasiA, KramerJM, et al.Fulminant liver failure in association with the emetic toxin of Bacillus cereus. N Engl J Med1997;336:1142. CrossRef

314. MorrisJG, Jr.“Noncholera”Vibrio species. In: BlaserMJ, SmithPD, RavdinJI, et al. (eds). Infections of the gastrointestinal tract. New York: Raven Press, 1995:671.

315. GoodgameRW. Understanding intestinal spore‐forming protozoa: cryptosporidia, microsporidia, isospora, and cyclospora. Ann Intern Med1996;124:429. CrossRef

316. RautelinH, HanninenML, SivonenA, et al.Chronic diarrhea due to a single strain of Aeromonas caviae. Eur J Clin Microbiol Infect Dis1995;14:51. CrossRef

317. BhatnagarS, BhanMK, SommerfeltH, et al.Enteroaggregative Escherichia coli may be a new pathogen causing acute and persistent diarrhea. Scand J Infect Dis1993;25:579. CrossRef

318. ChenXM, KeithlyJS, PayaCV, LaRussoNF. Cryptosporidiosis. N Engl J Med2002;346:1723. CrossRef

319. WilcoxMH, CookAM, EleyA, SpencerRC. Aeromonas spp as a potential cause of diarrhoea in children. J Clin Pathol1992;45:959. CrossRef

320. BaertF, PeetermansW, KnockaertD. Yersiniosis: the clinical spectrum. Acta Clin Belg1994;49:76.

321. Stolk‐EngelaarVM, Hoogkamp‐KorstanjeJA. Clinical presentation and diagnosis of gastrointestinal infections by Yersinia enterocolitica in 261 Dutch patients. Scand J Infect Dis1996;28:571. CrossRef

322. WongCS, JelacicS, HabeebRL, et al.The risk of the hemolytic–uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med2000;342:1930. CrossRef

323. HoveH, TvedeM, MortensenPB. Antibiotic‐associated diarrhoea, Clostridium difficile, and short‐chain fatty acids. Scand J Gastroenterol1996;31:688. CrossRef

324. PonnuvelKM, RajkumarR, MenonT, SankaranarayananVS. Role of Candida in indirect pathogenesis of antibiotic associated diarrhoea in infants. Mycopathologia1996;135:145. CrossRef

325. MarooS, LaMontJT. Recurrent Clostridium difficile. Gastroenterology2006;130:1311. CrossRef

326. GoldbergMB, RubinRH. The spectrum of Salmonella infection. Infect Dis Clin North Am1988;2:571.

327. Bruce‐JonesPN, AllenSC. Variations of invasive Salmonella infection in elderly people. Br J Clin Pract1996;50:470.

328. EdwardsBH. Salmonella and Shigella species. Clin Lab Med1999;19:469.

329. FerreraPC, JeanjaquetMS, MayerDM. Shigella‐induced encephalopathy in an adult. Am J Emerg Med1996;14:173. CrossRef

330. HughesRA, HaddenRD, GregsonNA, et al.Pathogenesis of Guillain–Barré syndrome. J Neuroimmunol1999;100:74. CrossRef

331. McCarthyN, GieseckeJ. Incidence of Guillain–Barré syndrome following infection with Campylobacter jejuni. Am J Epidemiol2001;153:610. CrossRef

332. PerlesZ, Bar‐ZivJ, GranotE.Brain edema: an underdiagnosed complication of Shigella infection. Pediatr Infect Dis J1995;14:1114. CrossRef

333. ThomsonGT, DeRubeisDA, HodgeMA, et al.Post‐Salmonella reactive arthritis: late clinical sequelae in a point source cohort. Am J Med1995;98:13. CrossRef

334. PowellDW. Approach to the patient with diarrhea. In: KelleyWN(ed.). Textbook of internal medicine. Philadelphia: Lippincott–Raven, 1997:617.

335. ParksSI, GiannellaR. Approach to the adult patient with acute diarrhea. Gastroenterol Clin North Am1993;22:483.